David Topper
About David Topper
David Topper is a seasoned financial executive with extensive experience in capital markets and biopharmaceuticals, currently serving as the Chief Financial Officer.
David Topper - Chief Financial Officer
David Topper currently serves as the Chief Financial Officer. His extensive financial background and decades-long experience in leadership roles position him as a significant contributor to the company's financial strategy and operations.
David Topper's Education and Expertise
David Topper holds an M.B.A. from Stanford University, a prestigious institution that has equipped him with advanced business and financial acumen. He also earned a B.A. from Duke University, providing a robust academic foundation for his career in finance. His expertise spans capital markets, corporate finance, and strategic financial management.
David Topper's Background in Financial Leadership
David Topper has built a significant career in the financial sector. He worked at J.P. Morgan for six years, taking on roles such as co-head of Equity Capital Markets, vice chairman, and chairman of the Commitments Committee. Before that, he spent 22 years at Morgan Stanley, where he held several leadership positions including co-head of Equity Capital Markets and managing director.
David Topper's Previous Roles
David Topper served as CFO at Inmagene Biopharmaceuticals, where he was responsible for overseeing financial operations. He also worked as a partner for capital markets at General Atlantic and Frazier Life Sciences. Additionally, he held the position of CFO and board director at Frazier Life Sciences Acquisition Corp, contributing to strategic financial decisions and governance.